Fresh Tracks Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Fresh Tracks Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q4 2023.
  • Fresh Tracks Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2023 was -$1.24M, a 72.7% increase year-over-year.
  • Fresh Tracks Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2023 was -$5.69M, a 73% increase year-over-year.
  • Fresh Tracks Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$5.69M, a 73% increase from 2022.
  • Fresh Tracks Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$21.1M, a 46.5% increase from 2021.
  • Fresh Tracks Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$39.5M, a 88.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$5.69M -$1.24M +$3.29M +72.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$8.98M $2.1M +$8.12M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$17.1M -$2.28M -$1.14M -99.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-13
Q1 2023 -$16M -$4.28M +$5.13M +54.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-11-13
Q4 2022 -$21.1M -$4.53M +$1.54M +25.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$22.6M -$6.02M +$7.24M +54.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$29.9M -$1.15M +$10M +89.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$39.9M -$9.41M -$405K -4.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$39.5M -$6.07M +$1.3M +17.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$40.8M -$13.3M -$8.93M -206% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$31.8M -$11.1M -$6.03M -118% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$25.8M -$9.01M -$4.9M -119% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$20.9M -$7.37M +$3.5M +32.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$24.4M -$4.33M +$455K +9.52% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$24.9M -$5.12M -$1.47M -40.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$23.4M -$4.1M +$477K +10.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 -$23.9M -$10.9M -$7.19M -196% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-18
Q3 2019 -$16.7M -$4.78M -$2.24M -88.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$14.4M -$3.65M -$102K -2.87% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$14.3M -$4.58M -$5.11M -969% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$9.24M -$3.67M +$58K +1.56% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-18
Q3 2018 -$9.29M -$2.54M +$547K +17.7% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-18
Q2 2018 -$9.84M -$3.55M -$232K -6.99% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-18
Q1 2018 -$9.61M $527K +$3.35M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-18
Q4 2017 -$13M -$3.73M -$956K -34.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$12M -$3.09M -$565K -22.4% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 -$11.4M -$3.32M -$2.07M -165% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$9.37M -$2.82M -$401K -16.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$8.97M -$2.77M -$417K -17.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$8.56M -$2.52M -$2.22M -741% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 -$6.33M -$1.26M +$1.51M +54.6% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 -$7.84M -$2.42M +$1.4M +36.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
Q4 2015 -$9.24M -$2.36M +$2.28M +49.2% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$11.5M -$300K +$4.06M +93.1% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q2 2015 -$15.6M -$2.76M +$1.28M +31.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-10
Q1 2015 -$16.9M -$3.82M -$366K -10.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10
Q4 2014 -$16.5M -$4.63M -$2.44M -111% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$14.1M -$4.36M +$5.52M +55.8% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$19.6M -$4.04M +$5.84M +59.1% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$25.4M -$3.46M +$5.83M +62.8% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 -$31.2M -$2.19M +$5.36M +71% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-26
Q3 2013 -$36.6M -$9.88M -$2.16M -27.9% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-26
Q2 2013 -$34.4M -$9.88M -$2.01M -25.6% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-26
Q1 2013 -$32.4M -$9.28M -$9.53M -3904% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-26
Q4 2012 -$22.9M -$7.55M -$935K -14.1% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-14
Q3 2012 -$22M -$7.73M -$24.2M -147% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-14
Q2 2012 $2.19M -$7.87M +$538K +6.4% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-14
Q1 2012 $1.66M $244K +$8.94M Jan 1, 2012 Mar 31, 2012 10-K 2014-02-14
Q4 2011 -$7.28M -$6.61M Oct 1, 2011 Dec 31, 2011 10-K 2013-02-15
Q3 2011 $16.4M +$23.2M Jul 1, 2011 Sep 30, 2011 10-K 2013-02-15
Q2 2011 -$8.41M -$26K -0.31% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-15
Q1 2011 -$8.69M Jan 1, 2011 Mar 31, 2011 10-K 2013-02-15
Q3 2010 -$6.77M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 -$8.38M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.